Equity
€24,520 from €81,728 in 2006
Equity fell by 70% in 19 years.
APOTHEEK HUMBLET
Lifetime
20 annual accounts with figures on one time axis, 38 filings since 1988peak €289,568 (2020)
€90,354▼ 33.2%
lowest -€67,322 (2012)
-€24,289▼ €30,834
peak €81,728 (2006)
€24,520▼ 49.8%
€852,917▲ 1.7%
peak 3.5 FTE (2020)
1.6 FTE▼ 5.9%
Board2 names since 2007
1 directorANNEMIE HUMBLET MANAGEMENT BV
Owners
Documentsfilings and deeds
05-08-20265 days late
2025financial year
Gross margin from €135,268 to €90,354Loss of €24,289Equity from €48,809 to €24,520Investments €45,216
Key points
from the 2025 annual accountsDebts
€852,917 97% of the balance sheet
Financial debts 39%Suppliers 4%Taxes and wages 1%Other 56%
Of this, €719,645 falls due within a year.
Investments
€45,216 2.1 × depreciation
Green is investment, beige is depreciation. Land and buildings stand 13.1% higher than in 2024.
Staff
2 employees on 31-12-2025
In 2025, 1 person joined and 1 left.
Filings
38 annual accounts since 1988
Nine of the last ten came late. The 2021 accounts came latest: 74 days after the end of the period.
Position in the sector
2.8%
Lower solvency than 85% of companies in retail trade. Sector median 36.2% · 5,067 companies.
Checked score
68
Healthy
Financially stronger than 18% of micro companies in retail trade (NACE 47)
Probability in this band: 0.55% to 1.5%
Bankruptcy probability within 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.6% across 40,271 companies (NACE 47, micro).
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.6%
01-2025: 0.6%● unchanged vs 12-2024
02-2025: 0.6%● unchanged vs 01-2025
03-2025: 0.5%▼ -0.1 percentage points vs 02-2025
04-2025: 0.5%● unchanged vs 03-2025lowest value
05-2025: 0.5%● unchanged vs 04-2025
06-2025: 0.5%● unchanged vs 05-2025
07-2025: 0.7%▲ +0.2 percentage points vs 06-2025
08-2025: 0.9%▲ +0.2 percentage points vs 07-2025
09-2025: 0.9%● unchanged vs 08-2025
10-2025: 0.9%● unchanged vs 09-2025
11-2025: 0.9%● unchanged vs 10-2025
12-2025: 0.9%● unchanged vs 11-2025
01-2026: 0.9%● unchanged vs 12-2025
02-2026: 0.9%● unchanged vs 01-2026
03-2026: 0.8%▼ -0.1 percentage points vs 02-2026
04-2026: 0.8%● unchanged vs 03-2026
05-2026: 0.8%● unchanged vs 04-2026
06-2026: 0.8%● unchanged vs 05-2026
07-2026: 0.9%▲ +0.1 percentage points vs 06-2026
08-2026: 1.6%▲ +0.7 percentage points vs 07-2026highest value
09-2026: 0.6%▼ -1.0 percentage point vs 08-2026
10-2026: 0.6%● unchanged vs 09-2026
11-2026: 0.6%● unchanged vs 10-2026
Financial strengthWeak
Score breakdown
raises risk
Equity €24,520 (2.8% of total assets)
Sector: Retail trade (NACE 47)
lowers risk
Founded in 1987
Size: 1.6 FTE, total assets €877,437
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 21% of them on solvency, 18% on liquidity, 22% on profitability and 11% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 974 companies had the same profile as APOTHEEK HUMBLET has now. Each dot stands for 3 companies, two years later.
92.9%
were still trading
4.4%
stopped another way
2.3%
went bankrupt
Another 0.4% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of APOTHEEK HUMBLET itself: 0.6% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 974 companies, not a prediction for APOTHEEK HUMBLET. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.91 (0.99 in 2024), below 1. Short-term debt is 82% and cash 12.1% of total assets. 97.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises risk
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 5067 sector peers (2025).
NBB · sector comparisonPosition among 5067 sector peers
Solvency
better than 14%
← weakest
strongest →
raises risk · 2025 accounts filed 5 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-08-2026, 5 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
5 days late
2024
28 days late
2023
57 days late
2022
59 days late
2021
74 days late
2020
69 days late
2019
61 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 50 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 September (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- ANNEMIE HUMBLET MANAGEMENT 100%equity €1.6m (2025) · 2025 annual accounts of ANNEMIE HUMBLET MANAGEMENT
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0432846365
Resignation: VANDERBRUGGEN Madeleine (director)
“Beheer van apotheken; Managementactiviteiten van holdings:tussenkomen in het dagelijks…” (deed in Dutch) · Director discharge: VANDERBRUGGEN Madeleine · Gazette deed
1 director appointed, 2 reappointments
Reappointments: ANNEMIE HUMBLET MANAGEMENT BV and VANDERBRUGGEN Madeleine · Permanent representative: Humblet Anna · Appointment: ANNEMIE HUMBLET MANAGEMENT BV (managing director) · General meeting of 01-07-2021 · Gazette deed
First establishment
APOTHEEK, Grote Markt 14, Zoutleeuw
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| APOTHEEK HUMBLET Zoutleeuw | €877,437 | €90,354 | 2.8% | 1.6 |
| Deraphar Zelzate | €778,926 | €104,127 | 34.7% | 1.9 |
| PHARMACIE DE GROOTE Walcourt | €745,544 | €105,092 | 57.8% | 1.3 |
| Apotheek As As | €783,998 | €123,582 | 20.2% | 1.5 |
| PHARMACIE D'ANDENELLE Andenne | €675,423 | €101,294 | 22.7% | 1.9 |
| Apotheek DC Turnhout Turnhout | €787,383 | €131,339 | 24.8% | 1.7 |
| APOTHEEK THIELS Genk | €823,792 | €101,953 | 25.2% | 1 |
These companies have the same main activity as APOTHEEK HUMBLET: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €675,000 and €824,000, founded between 1984 and 1989.
Official details
Source: KBO- Status
- Active since 18-12-1987Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2025
- Establishment unit
- 2.032.638.0673440 Zoutleeuw, since 11-01-1988
- Financial year end
- 31 December
- Peppol
- Reachable since 25-06-2025
Annual accounts 2025
- ≈ €440,000estimated
- €877,437▼ 1.1%
- Employeeson 31-12-2025
- 2=
- Filing
- Filed on 05-08-2026
Insights on APOTHEEK HUMBLET
APOTHEEK HUMBLET has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €24,520 and a net result of -€24,289.
Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 14% of 5,067 sector peers (NACE 47, financial year 2025).
The computed 12-month bankruptcy probability is 0.6% (low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about APOTHEEK HUMBLET
- What is the company number of APOTHEEK HUMBLET?
- The company number of APOTHEEK HUMBLET is 0432.846.365. The VAT number is the same number with BE in front: BE 0432.846.365.
- Where is APOTHEEK HUMBLET based?
- The registered office is at Grote Markt 14, 3440 Zoutleeuw.Company details
- What does APOTHEEK HUMBLET do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK HUMBLET?
- APOTHEEK HUMBLET is a public limited company (NV).
- When was APOTHEEK HUMBLET founded?
- APOTHEEK HUMBLET was founded on 18-12-1987.
- Is APOTHEEK HUMBLET still active?
- Yes, APOTHEEK HUMBLET is an active enterprise in the KBO register.
- How many employees does APOTHEEK HUMBLET have?
- APOTHEEK HUMBLET had an average of 1.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK HUMBLET fall under?
- In its 2025 annual accounts, APOTHEEK HUMBLET states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of APOTHEEK HUMBLET?
- The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €90,354 and 74 comparable companies (NACE 477). It probably lies between €220,000 and €630,000.
- Is APOTHEEK HUMBLET profitable?
- In financial year 2025, APOTHEEK HUMBLET made a loss of €24,289.
- Where can I find the annual accounts of APOTHEEK HUMBLET?
- APOTHEEK HUMBLET filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK HUMBLET due?
- APOTHEEK HUMBLET must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.